Roles of Lymphocyte Kv1.3-Channels in the Pathogenesis of Renal Diseases and Novel Therapeutic Implications of Targeting the Channels

<div>Therapeutic implications of targeting lymphocyte Kv1.3-channels in the treatment of CKD. In addition to benidipine, one of the calcium channel blockers (CCBs), macrolide antibiotics, and statins, which effectively inhibit lymphocyte Kv1.3-channels, could also potentially be useful in the treatment or the prevention of chronic kidney disease (CKD).</div>

Mediators of Inflammation

fig6

Figure 6

Figure 6: Roles of Lymphocyte Kv1.3-Channels in the Pathogenesis of Renal Diseases and Novel Therapeutic Implications of Targeting the Channels 